Overview

This Solution Provider Webinar is brought to you by DIA in cooperation with BioClinica.
Within oncology drug development, sponsors face the challenge of effectively evaluating potential cardiovascular toxicity. The emerging clinical discipline of ‘Cardio-Oncology’ (CO) aims to promote safer drugs and better outcomes for cancer patients through the use of multimodal strategies for assessing drug dependent cardiac abnormalities. In this webinar, experts will highlight state-of-the-art approaches and key considerations for establishing successful cardiovascular safety strategies for oncology clinical trials. The webinar will provide an overview of the emerging CO discipline and will feature a case study highlighting the design and innovative cardiovascular imaging methodologies used to detect and monitor cardiovascular safety for a recent FDA approved Multiple Myeloma drug.
TO REGISTER FOR THIS EVENT PLEASE CLICK HERE
Have an account?